Keywords : surgical device, bariatric surgical device, Clamps , Trocar
This report analyzes the US and European markets for Bariatric (Obesity) Surgical Devices in Millions of US$. The US market for Bariatric Surgical Devices is analyzed by the following segments: Gastric Bypass Devices, and Gastric Banding Devices. The European market is separately analyzed by the following segments: Adjustable Gastric Banding Devices, Gastric Bypass Devices, and Intragastric Balloon Devices. Annual forecasts are provided for the ...
More »
Search ReportLinker
The Largest Collection of Market Research Reports
» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides
From +200,000 authoritative sources
This report analyzes the US and European markets for Bariatric (Obesity) Surgical Devices in Millions of US$. The US market for Bariatric Surgical Devices is analyzed by the following segments: Gastric Bypass Devices, and Gastric Banding Devices. The European market is separately analyzed by the following segments: Adjustable Gastric Banding Devices, Gastric Bypass Devices, and Intragastric Balloon Devices. Annual forecasts are provided for the period of 2005 through 2015. The report profiles 49 companies including many key and niche players worldwide such as Allergan, Inc., Cousin Biotech, Covidien Ltd., Ethicon Endo-Surgery, Inc., Helioscopie SA, Medical Innovation Development Company, PARÉ Surgical, Inc., Satiety, Inc., Silimed Ltda., and Surgical IOC. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Surgical Equipment Industry in Spain
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-3
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW II-1
Obesity Assumes Epidemic Proportions II-1
Growing Problem of Obesity in Asia Particularly ChinaII-1
Obesity - Quick Statistics II-2
Table 1: Global Overweight Prevalence (2006): Overweight
Population (%) of Select Countries (BMI > 25) (includes
corresponding Graph/Chart) II-3
Table 2: Obese and Overweight & Obese Population in the World
(2009): Percentage Share Breakdown by Region for US, European
Union, and Rest of World (includes corresponding Graph/Chart) II-3
Table 3: Abdominal Obesity Prevalence (%) by Region and Sex
(includes corresponding Graph/Chart) II-4
Surgery Provides Hope for Morbidly Obese Patients II-4
Growing Obesity Prevalence Drives Development of Weight Loss
Therapies II-5
2. MARKET DYNAMICS II-6
Relevance of Bariatric Surgery in Pediatrics II-6
Sleeve Gastrectomy - Challenging the Growth of Banding Procedures II-6
Compliance Trends with Physician Advise in Post-Surgery Scenario II-7
Recommendation Compliance After Surgery - Weight Loss in
Compliant and Non-Compliant Patients II-7
Risk of Bariatric Surgery on Pregnancy II-7
Stomaphyx Surgery - Addressing Post-Surgical Complications II-8
VBLOC - An Alternative to Bariatric Surgery II-8
Endobarrier - An Experimental Device Offers Alternative to
Surgery II-8
Competition Intensifies in the Bariatric Surgery Market II-8
3. AN INTRODUCTION TO OBESITY II-10
Obesity - A Conceptual DefinitionII-10
Childhood Obesity II-10
Causes of Obesity II-10
Dietary Habits II-11
Sedentary Lifestyle II-11
Genetic Factors II-11
Medical and Psychiatric Illnesses II-11
Socioeconomic Factors II-12
Diagnosis of Obesity II-12
Body Mass Index (BMI) II-12
Classification of Obesity as per BMI II-12
Classification for Class III Obesity II-13
Deriving Body Fat Percentage from BMI II-13
Central Obesity II-13
Central Obesity in Men and Women - Criteria for
Identification Using Absolute Waist Circumference and
Waist-Hip Ratio Methods II-14
Impact of Obesity on Health II-14
Mortality II-14
Morbidity II-14
Major Obesity-Related Diseases II-14
Obesity Treatment II-15
Diet Therapy II-16
Lifestyle Modification II-16
Pharmacotherapy II-16
Medical Devices II-16
Bariatric Surgery II-16
Clinical Protocols for Obesity Treatment II-16
4. BARIATRIC SURGERY - AN INSIGHT II-17
Defining Bariatrics II-17
Bariatric Surgery II-17
Patient Eligibility for Bariatric Surgery II-17
Role of Technologies in the Growth of Bariatric Surgery II-18
Endoluminal and Transgastric Surgeries II-18
Laparoscopy II-18
Endoscopy in Bariatric Surgery II-19
Advantages of Bariatric Surgery II-19
Disadvantages of Bariatric Surgery II-19
5. SURGICAL OPTIONS FOR OBESITY TREATMENT II-21
SURGICAL TREATMENT FOR OBESITY II-21
Classification of Bariatric Surgery Procedures II-21
Restrictive Procedures II-21
Vertical Banded Gastroplasty II-22
Laparoscopic Adjustable Gastric Banding II-22
World Estimates and Forecasts II-22
Table 4: World Recent Past, Current & Future Analysis for
Bariatric Surgery: Annual Number of Gastric Banding
Procedures for Years 2005 through 2015 (in Thousands)
(includes corresponding Graph/Chart) II-23
Eligibility Criteria for Gastric Banding Patients II-23
Advantages of Gastric Banding II-23
Adverse Effects of Banding II-24
Malabsorptive ProceduresII-24
Biliopancreatic Diversion Procedure II-25
Biliopancreatic Diversion with Duodenal Switch II-25
Benefits & Drawbacks of the Procedure II-26
Combination Procedures II-26
Gastric Bypass Surgery II-26
Table 5: Effectiveness of Gastric Bypass Surgery (includes
corresponding Graph/Chart) II-27
Surgical Techniques for Gastric Bypass II-27
Variations of Gastric Bypass II-27
Loop Gastric BypassII-27
Mini Gastric BypassII-28
Table 6: Key Performance Characteristics of Laparoscopic
Mini Gastric Bypass Surgery II-28
Long-Limb Gastric Bypass II-28
Gastric Bypass, Roux En-Y (Proximal) II-28
Gastric Bypass, Roux en-Y (Distal) II-29
Open Vs Laparoscopic Gastric Bypass Surgery II-29
Complications of Gastric Bypass Procedure II-29
Anastamotic LeakageII-29
Anastamotic Stricture II-29
Dumping Syndrome II-29
Major Complications of Laparoscopic Gastric Bypass II-30
Sleeve Gastrectomy II-30
Analysis of Various Bariatric Procedures II-31
Table 7: A Comparative Analysis of Various Bariatric Surgery
Procedures II-31
Table 8: Efficacy Rates of Bariatric Procedures (At 2 Year of
Surgery)II-32
Gastric Banding Vs Gastric BypassII-32
Table 9: Comparison of Gastric Band & Gastric Bypass
Surgeries II-33
6. BARIATRIC SURGERY DEVICESII-34
Adjustable Gastric BandsII-34
Background II-34
Available Gastric BandsII-34
Adjustable Gastric Bands Marketed in the US and Europe II-35
Allergan & Ethicon Vie for Global Gastric Band Market Share II-35
Table 10: Leading Players in the Global Gastric Bands Market
(2007): Percentage Share Breakdown of Value Sales for
Allergan, Johnson & Johnson/Ethicon, and Others (includes
corresponding Graph/Chart) II-36
Lap-Band Vs Realize Band II-36
Intragastric BalloonsII-36
Implantable Gastric Stimulator (IGS) II-37
Surgical Clamps/Gastric Surgery Clamps II-37
Clip Applier II-37
Endo Stitch II-38
Pneumoperitoneum Needle II-38
Surgical Staple II-38
Trocars II-38
7. RESEARCH/STUDY FINDINGS II-39
Bariatric Surgery Reduces Complications Associated with NAFLD II-39
Research Finds Lower Maternal Risks Among Surgery- Treated
Obesity Patients II-39
Metabolic Syndrome Affects In-Hospital Outcomes After
Bariatric Surgery II-40
Researchers Assess Pulmonary Aspiration Risk in Bariatric
Surgery Patients II-41
Post-Operative Outcomes of Bariatric Surgeries II-41
Gastric Bypass Surgery Improves Immune Response of Patients II-41
Bariatric Surgery Reduces Cancer Risk II-41
Study Shows Need for Re-Surgery in Banding Surgery Patients II-42
Gastric Banding Surgery Improves Resistance to InsulinII-42
8. PRODUCT INNOVATIONS/INTRODUCTIONS II-43
Covidien Introduces Versaport™ Plus Bladeless Trocar Line II-43
West Penn Bariatric Surgery Center Commences use of REALIZE
Gastric Band II-43
Ethicon Receives FDA Approval to Market REALIZE™ II-43
Swan Medical Devices Introduces Intraluminal Gastroplasty Device II-43
9. RECENT INDUSTRY ACTIVITY II-44
Allergan Acquires EndoArt II-44
Allergan and Covidien to Co-promote Lap-Band II-44
Taiwan Approves Intragastric Balloon Treatment II-44
Cellular Technical Services Takes Over SafeStitch II-44
USGI Medical to Use EOS II-45
Synovis Acquires 4Closure™ Surgical Fascia Closure System II-45
Allergan Acquires InamedII-45
Medtronic Acquires Transneuronix II-45
EnteroMedics and Mayo Enter into R&D Agreement II-46
10. FOCUS ON SELECT PLAYERS II-47
Allergan, Inc. (US) II-47
Cousin Biotech (France) II-47
Covidien Ltd. (Bermuda) II-47
Ethicon Endo-Surgery, Inc. (US) II-48
Helioscopie SA (France) II-48
Medical Innovation Development Company (France) II-48
PARÉ Surgical, Inc. (US)II-48
Satiety, Inc. (US) II-48
Silimed Ltda (Brazil)II-49
Surgical IOC (France)II-49
III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
OutlookIII-1
Obesity - A Major Concern for Healthcare Industry III-1
Factors Contributing to Rising Incidence of Obesity III-1
A Quick Glance at Obesity Statistics III-2
Table 11: Obesity-Affected Population in the US (2009):
Percentage Share Breakdown by Age Group (includes
corresponding Graph/Chart) III-3
Table 12: Proportion (%) of Obesity in the US Overweight
Population by Age Group (includes corresponding
Graph/Chart) III-3
Table 13: US Obesity Rate (2007): Prevalence Rate by
Leading States III-4
Bariatric Surgery - Ultimate Option for Obesity Treatment III-5
Bariatric Surgery - Fast FactsIII-5
Focus on Physical Well-Being Boosts Bariatric Surgery Market III-5
Growth Drivers III-6
Market Restraints III-6
Rapid Growth in Bariatric Surgery Devices Market III-6
Surgery Market for Adolescent Obesity- Slow & Steady Growth III-7
Gastric Banding - A Market Set for Rapid Growth III-7
Laparoscopic Adjustable Gastric Banding Gains Popularity III-7
LGB Vs LGBP - Cost Comparison III-8
Robot-Assisted Gastric Bypass Surgery Rises in Popularity III-8
Reimbursement ScenarioIII-8
Insurance CoverageIII-9
CMS Offers Coverage for Bariatric Surgery III-9
Lack of Sufficient Coverage - A Major Obstacle III-9
Competition Intensifies in the US Gastric Banding Market III-10
Table 14: Leading Players in the US Adjustable Gastric
Banding Market (2006 & 2008): Percentage Share Breakdown of
Revenues for Allergan and Johnson & Johnson III-10
Product Launches III-11
Strategic Corporate Developments III-12
Key Players III-14
Allergan, Inc. III-14
Ethicon Endo-Surgery, Inc. III-14
PARÉ Surgical, Inc. III-14
Satiety, Inc. III-14
B.Market Analytics III-15
Table 15: US Recent Past, Current & Future Analysis for
Bariatric Surgery: Annual Number of Gastric Bypass and
Gastric Banding Procedures for Years 2005 through 2015 (in
Thousands) (includes corresponding Graph/Chart) III-15
Table 16: US 10-Year Perspective for Bariatric Surgical
Procedures by Segment - Percentage Breakdown of Gastric
Bypass and Gastric Banding Procedures for Years 2006, 2009 &
2015 III-15
Table 17: US Recent Past, Current & Future Analysis for
Bariatric Surgical Devices by Segment - Gastric Bypass and
Gastric Banding Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2005 through 2015
(includes corresponding Graph/Chart) III-16
Table 18: US 10-Year Perspective for Bariatric Surgical
Devices by Segment - Percentage Breakdown of Annual Revenues
for Gastric Bypass and Gastric Banding Markets for Years
2006, 2009 & 2015 III-16
2. EUROPE III-17
A.Market Analysis III-17
OutlookIII-17
Obese Population in Europe III-17
Table 19: Obese and Overweight & Obese Population in the
European Union (2009): Percentage Share Breakdown by Age
Group III-17
Table 20: Obesity Prevalence (2007) in Select European
Union Countries: Obesity Rates by Gender (includes
corresponding Graph/Chart) III-18
Table 21: Europe Obesity Prevalence (2007) by Gender and
Age Category (in 000s) (includes corresponding Graph/Chart) III-18
Bariatric Surgery in Europe III-19
Growing Awareness Levels to Boost Surgery Devices Market III-19
Factors Driving the European Bariatric Surgery Devices Market III-20
Factors Restraining Growth in the European Bariatric Surgery
Devices Market III-20
Pricing Scenario III-20
Gastric Bypass Surgery Gains Strength III-20
Reimbursement Scenario in Europe III-21
Reimbursement Policies in Select European CountriesIII-22
Competitive Landscape III-22
Table 22: Leading Players in the European Bariatric
Surgical Devices Market (2007): Percentage Share Breakdown
of Revenues for Ethicon Endo Surgery, Allergan/Inamed,
Covidien, and Others (includes corresponding Graph/Chart) III-23
B.Market Analytics III-23
Table 23: European Recent Past, Current & Future Analysis
for Bariatric Surgical Devices by Geographic Region -
France, Germany, Italy, UK, Spain, and Rest of Europe
Markets Independently Analyzed with Annual Revenues in US$
Million for Years 2005 through 2015 (includes corresponding
Graph/Chart) III-23
Table 24: European 10-Year Perspective for Bariatric
Surgical Devices by Geographic Region - Percentage Breakdown
of Annual Revenues for France, Germany, Italy, UK, Spain,
and Rest of Europe Markets for Years 2006, 2009 & 2015
(includes corresponding Graph/Chart) III-24
Table 25: European Recent Past, Current & Future Analysis
for Bariatric Surgical Devices by Segment - Adjustable
Gastric Banding, Gastric Bypass Devices, and Intragastric
Balloon Devices Markets Independently Analyzed with Annual
Revenues in US$ Million for Years 2005 through 2015
(includes corresponding Graph/Chart) III-25
Table 26: European 10-Year Perspective for Bariatric
Surgical Devices by Segment - Percentage Breakdown of Annual
Revenues for Adjustable Gastric Banding, Gastric Bypass
Devices, and Intragastric Balloon Devices Markets for Years
2006, 2009 & 2015 (includes corresponding Graph/Chart) III-26
2a. France III-27
A.Market Analysis III-27
OutlookIII-27
Obesity - A Major Health Concern III-27
Key Players III-27
Cousin Biotech III-27
Helioscopie SA III-27
Medical Innovation Development Company III-28
Surgical IOC III-28
B.Market Analytics III-29
Table 27: French Recent Past, Current & Future Analysis for
Bariatric Surgical Devices by Segment - Adjustable Gastric
Banding, Gastric Bypass Devices, and Intragastric Balloon
Devices Markets Independently Analyzed with Annual
Revenuesin US$ Million for Years 2005 through 2015 (includes
corresponding Graph/Chart) III-29
Table 28: French 10-Year Perspective for Bariatric Surgical
Devices by Segment - Percentage Breakdown of Annual Revenues
for Adjustable Gastric Banding, Gastric Bypass Devices, and
Intragastric Balloon Devices Markets for Years 2006, 2009 &
2015 (includes corresponding Graph/Chart) III-30
2b. GERMANY III-31
A.Market Analysis III-31
OutlookIII-31
Overview III-31
Bariatric Solutions GmbH - A Key Player III-31
B.Market Analytics III-32
Table 29: German Recent Past, Current & Future Analysis for
Bariatric Surgical Devices by Segment - Adjustable Gastric
Banding, Gastric Bypass Devices, and Intragastric Balloon
Devices Markets Independently Analyzed with Annual Revenues
in US$ Million for Years 2005 through 2015 (includes
corresponding Graph/Chart) III-32
Table 30: German 10-Year Perspective for Bariatric Surgical
Devices by Segment - Percentage Breakdown of Annual Revenues
for Adjustable Gastric Banding, Gastric Bypass Devices, and
Intragastric Balloon Devices Markets for Years 2006, 2009 &
2015 (includes corresponding Graph/Chart) III-33
2c. ITALY III-34
Market Analysis III-34
Table 31: Italian Recent Past, Current & Future Analysis for
Bariatric Surgical Devices by Segment - Adjustable Gastric
Banding, Gastric Bypass Devices, and Intragastric Balloon
Devices Markets Independently Analyzed with Annual Revenues
in US$ Million for Years 2005 through 2015 (includes
corresponding Graph/Chart) III-34
Table 32: Italian 10-Year Perspective for Bariatric Surgical
Devices by Segment - Percentage Breakdown of Annual Revenues
for Adjustable Gastric Banding, Gastric Bypass Devices, and
Intragastric Balloon Devices Markets for Years 2006, 2009 &
2015 (includes corresponding Graph/Chart) III-35
2d. UNITED KINGDOM III-36
A.Market Analysis III-36
OutlookIII-36
Overview III-36
B.Market Analytics III-37
Table 33: UK Recent Past, Current & Future Analysis for
Bariatric Surgical Devices by Segment - Adjustable Gastric
Banding, Gastric Bypass Devices, and Intragastric Balloon
Devices Markets Independently Analyzed with Annual Revenues
in US$ Million for Years 2005 through 2015 (includes
corresponding Graph/Chart) III-37
Table 34: UK 10-Year Perspective for Bariatric Surgical
Devices by Segment - Percentage Breakdown of Annual Revenues
for Adjustable Gastric Banding, Gastric Bypass Devices, and
Intragastric Balloon Devices Markets for Years 2006, 2009 &
2015 (includes corresponding Graph/Chart) III-38
2e. SPAIN III-39
Market Analysis III-39
Table 35: Spanish Recent Past, Current & Future Analysis for
Bariatric Surgical Devices by Segment - Adjustable Gastric
Banding, Gastric Bypass Devices, and Intragastric Balloon
Devices Markets Independently Analyzed with Annual Revenues
in US$ Million for Years 2005 through 2015 (includes
corresponding Graph/Chart) III-39
Table 36: Spanish 10-Year Perspective for Bariatric Surgical
Devices by Segment - Percentage Breakdown of Annual Revenues
for Adjustable Gastric Banding, Gastric Bypass Devices, and
Intragastric Balloon Devices Markets for Years 2006, 2009 &
2015 (includes corresponding Graph/Chart) III-40
2f. REST OF EUROPE III-41
A.Market Analysis III-41
Overview III-41
Gastric Banding Market Gains Strength III-41
BelgiumIII-41
The Netherlands III-41
Juvenile Obesity - A Major Cause of Concern III-41
FinlandIII-42
Sweden III-42
Strategic Corporate Developments III-42
New2DM S.A (Luxembourg) - A Major Player III-42
B.Market Analytics III-43
Table 37: Rest of Europe Recent Past, Current & Future
Analysis for Bariatric Surgical Devices by Segment -
Adjustable Gastric Banding, Gastric Bypass Devices, and
Intragastric Balloon Devices Markets Independently Analyzed
with Annual Revenues in US$ Million for Years 2005 through
2015 (includes corresponding Graph/Chart) III-43
Table 38: Rest of Europe 10-Year Perspective for Bariatric
Surgical Devices by Segment - Percentage Breakdown of Annual
Revenues for Adjustable Gastric Banding, Gastric Bypass
Devices, and Intragastric Balloon Devices Markets for Years
2006, 2009 & 2015 (includes corresponding Graph/Chart) III-44
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 49 (including Divisions/Subsidiaries - 64)
